Aurora: Alberta Securities Commission Dismisses Curaleaf's Application to Halt ATM
The Alberta Securities Commission dismissed Curaleaf's request to halt Aurora's at-the-market (ATM) program. Aurora called the move a distraction, arguing Curaleaf's hostile takeover bid undervalues the company. Aurora reported Q1 FY2027 revenue of $67.6M, gross profit of $35.6M, and a net loss of $4M. Curaleaf's bid values Aurora at approximately $272M.
How this was made
The 30-second read
Why it matters
The regulator’s dismissal reduces the probability of an immediate procedural constraint on Aurora’s ATM, shifting the contest back toward valuation, tender behavior, and any competing offers.
Market read
A regulator denied a takeover-related attempt to stop Aurora’s ATM, affecting dilution/financing uncertainty during the hostile bid.
What to watch
The article does not quantify how much Aurora could raise via the ATM or whether it will actually accelerate issuance, which could limit the practical impact on near-term dilution risk.
Background
Curaleaf launched a hostile takeover bid for Aurora in August and sought a regulatory halt of Aurora’s previously disclosed ATM program during the contest.
Ticker impact
Alberta Securities Commission dismissed Curaleaf’s bid to halt Aurora’s at-the-market (ATM) share issuance during an ongoing hostile takeover.
Likely modest relief for Aurora as the ATM can proceed, though takeover overhang may still cap upside.
The decision is directly about Aurora’s ability to issue shares under its ATM program, but the article frames it within an ongoing hostile bid where valuation and tender outcomes remain the dominant drivers.
Alberta Securities Commission dismissed Curaleaf’s application to halt Aurora’s ATM, undermining Curaleaf’s attempt to pressure the target during its hostile bid.
Likely pressure on Curaleaf as one procedural hurdle to the hostile bid strategy is removed.
The ruling is unfavorable to Curaleaf’s stated objective, but the hostile bid’s valuation and Aurora’s response still determine the broader outcome.
Market effects
Highlights how Canadian cannabis issuers may retain capital-raising flexibility during takeover contests, potentially affecting perceived takeover dynamics in the sector.
Canadian regulatory process outcome may influence sentiment around other TSX/Canadian cannabis M&A disputes.
Limited direct global spillover, but it reinforces cross-border investor focus on EU-GMP and international expansion assets in cannabis consolidation.
Counterpoint
Even with the ATM allowed, Aurora’s board and shareholders may still reject the hostile bid, so the ruling may not materially change the endgame.
Key entities
- companyAurora Cannabis Inc.
Canadian cannabis producer with EU-GMP-certified facilities and an ATM program disclosed before the hostile bid.
- companyCuraleaf Holdings, Inc.
US-based cannabis company pursuing a hostile takeover of Aurora and seeking to halt Aurora’s ATM issuance.
- regulatorAlberta Securities Commission
Canadian securities regulator that dismissed Curaleaf’s application to halt Aurora’s ATM program.
